Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
Create a narrative
Our community narratives are driven by numbers and valuation.
Create a narrative
Weekly Picks
Alphabet
BL
BlackGoat
Community Contributor
Alphabet: The Under-appreciated Compounder Hiding in Plain Sight
Summary Google trades at ~18× forward earnings; the cheapest among the Magnificent 7 Market is too focused on AI threats to Search and antitrust noise Meanwhile, Google is executing across AI, Cloud, and YouTube Key AI differentiator: unmatched distribution across 3B+ users via Search, Gmail, YouTube, Android, Chrome, and Cloud Quietly building a world-class AI infrastructure behind the scenes; including proprietary TPUs and a vertically integrated stack YouTube generated $8.93B in Q1 ad revenue (up 10% YoY); subscriptions hit 270M Google Cloud revenue up 28% YoY to $12.3B; now profitable Optionality from long-term bets like Waymo, DeepMind, and Verily Risk/reward is compelling; a strong candidate to beat the market long term Overview Despite being part of the "Magnificent Seven," Google’s stock lags due to perceived risks around disruption of its Search business from AI competitors and mounting antitrust concerns. But under the hood, Google has quietly built one of the most compelling setups in tech: with deep AI leadership, multiple high-growth businesses, and optionality from long-term moonshots like Waymo.
View narrative
US$282.83
FV
32.8% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
19
users have liked this narrative
3
users have commented on this narrative
53
users have followed this narrative
Updated
narrative
Planet Labs PBC
AN
andreas_eliades
Community Contributor
Planet Labs: At The Heart Of The Emerging New Space Boom
Planet Labs leads the EO market with the largest satellite constellation, poised to capitalize on the growing demand for Earth Observation and geospatial data from companies and governments. Plunging space launch and GPU computation costs combined with advancements in CubeSat and AI technologies are boosting the utility of Earth Observation data.
View narrative
US$11.31
FV
45.4% undervalued
intrinsic discount
30.00%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
1
users have commented on this narrative
58
users have followed this narrative
New
narrative
Exxon Mobil
AG
Agricola
Community Contributor
Exxon in Guyana 5 year forecast Low $135 to High $189
Previous mistake rectified. So as pointed out in the comments, Chevron won the Hess bid (rather than Exxon) and took a large portion of the Stabroek block.
View narrative
US$174.00
FV
37.0% undervalued
intrinsic discount
12.97%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
4
users have commented on this narrative
13
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Community Investing Ideas
Load previous narratives
LASACO Assurance
WA
WaneInvestmentHouse
Community Contributor
LASACO Assurance Plc H1/Q2 result - Solid Asset Growth Undermined by Cost Pressure and Declining Profitability
Despite robust asset and revenue growth, LASACO Assurance Plc posted a significant decline in profitability in H1 2025, with a swing to pre-tax loss. This reflects rising cost pressure, particularly from insurance service expenses and reinsurance costs.
View narrative
₦2.96
FV
12.2% undervalued
intrinsic discount
116.24%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
6
users have commented on this narrative
8
users have followed this narrative
Updated
narrative
Sterling Financial Holdings
WA
WaneInvestmentHouse
Community Contributor
Sterling Financial Holdings Company Plc – H1 2025 Performance Review
Sterling Financial Holdings Company Plc – H1 2025 Performance Review Thesis: Sterling Financial Holdings Company Plc (Sterling Holdings) demonstrated a strong financial performance in H1 2025, marked by significant growth in profitability and operational efficiency. These results affirm the company's solid fundamentals and robust growth trajectory, supporting a positive investment outlook with moderate caution due to rising cost pressures and macro-financial risks.
View narrative
₦6.37
FV
2.0% overvalued
intrinsic discount
82.05%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
2
users have commented on this narrative
6
users have followed this narrative
Updated
narrative
BUA Foods
WA
WaneInvestmentHouse
Community Contributor
BUA Foods Plc H1/Q2- Strong Operating Momentum Amid Macroeconomic Volatility
BUA Foods Plc H1/Q2- Strong Operating Momentum Amid Macroeconomic Volatility BUA Foods Plc delivered an impressive performance in H1 2025, showcasing significant growth in revenue and profit across both group and company levels, despite the macroeconomic headwinds and exchange rate volatility. The company's ability to maintain high margins and generate robust profits reinforces its position as a resilient player in Nigeria’s consumer goods and food manufacturing sector.
View narrative
₦375.00
FV
28.9% overvalued
intrinsic discount
17.64%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
4
users have commented on this narrative
10
users have followed this narrative
Updated
narrative
Neimeth International Pharmaceuticals
WA
WaneInvestmentHouse
Community Contributor
Neimeth Pharmaceuticals Delivers Strong Turnaround in H1 2025 Despite Financing Cost Pressures
Neimeth Pharmaceuticals Delivers Strong Turnaround in H1 2025 Despite Financing Cost Pressures Neimeth International Pharmaceuticals Plc posted a robust recovery in its half-year 2025 earnings, underpinned by strong revenue growth and operational efficiency, despite the lingering drag of elevated finance costs. Key Highlights: Revenue Surge : Neimeth reported a 76% year-on-year increase in revenue to ₦2.91 billion in H1 2025, up from ₦1.66 billion in H1 2024.
View narrative
₦7.38
FV
5.1% undervalued
intrinsic discount
5.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
7
users have commented on this narrative
10
users have followed this narrative
Updated
narrative
Aradel Holdings
WA
WaneInvestmentHouse
Community Contributor
Aradel Holdings Plc H1/Q2 Result - Solid Half-Year Performance Despite Cost Pressures
Aradel Holdings Plc H1/Q2 Result - Solid Half-Year Performance Despite Cost Pressures Aradel Holdings Plc delivered a resilient H1 2025 performance, underpinned by impressive revenue growth of +37.18% YoY to ₦368 billion and a pre-tax profit increase of +17.89% YoY to ₦191.3 billion , despite significant margin pressures in Q2. The company continues to demonstrate strong fundamentals and cash-generating ability, supported by its diversified revenue streams from crude oil, refined products, and gas.
View narrative
₦600.16
FV
13.4% undervalued
intrinsic discount
3.71%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
15
users have commented on this narrative
19
users have followed this narrative
Updated
narrative
Heineken
IV
Ivoed
Community Contributor
Heineken's Future Cash Flows Will Drive Value Beyond Expectations
1. Discounted Cash Flow (DCF) Method The DCF method is central to this valuation.
View narrative
€77.50
FV
13.0% undervalued
intrinsic discount
6.62%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
New
narrative
Samudera Shipping Line
RY
Ryan_G
Community Contributor
Samudera Shipping Sets Course for Long-Term Value with Fleet Modernization
An Editorial: Samudera Shipping (S56) – Navigating Volatility Towards Value Samudera Shipping Line Ltd (S56), a key player in Asia's marine shipping landscape, finds itself at a fascinating juncture. Our recent comprehensive valuation analysis, leveraging Discounted Cash Flow (DCF), Dividend Discount Model (DDM), and Market Multiples, suggests a synthesized fair value range of SGD 1.10 to SGD 2.20 per share.
View narrative
S$1.65
FV
38.8% undervalued
intrinsic discount
17.37%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
New
narrative
Hour Glass
RY
Ryan_G
Community Contributor
Hour Glass Gains Intrinsic Value Under Future Market Conditions
The HourGlass (AGS): A Deep Dive into Intrinsic Value and Future Potential The HourGlass (AGS), a prominent luxury watch retailer based in Singapore, appears to be a compelling investment opportunity, currently trading below its estimated intrinsic value. A thorough analysis, focusing on its operational strength and future prospects, suggests a disconnect between its market price and fundamental worth.
View narrative
S$3.18
FV
36.8% undervalued
intrinsic discount
16.98%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
Updated
narrative
Duopharma Biotech Berhad
HA
Haha94
Community Contributor
Anticipate Expansion in Duopharma Biotech as Leadership Prepares for Transition
Duopharma Biotech Bhd (KLSE: DPHARMA, ticker 7148) Healthcare – Pharmaceuticals / Biotech Investment Review Recommendation: HOLD (Initiated) Key Metrics Company Overview Duopharma Biotech Bhd is a leading pharmaceutical manufacturer in Malaysia, involved in the research, development, manufacturing, and distribution of generic and specialty pharmaceutical products. Its operations span: Ethical Classic : General therapeutic generics (e.g., cardiovascular, anti-infectives) Ethical Specialty : Bio-similars for oncology, renal, and metabolic diseases Consumer Healthcare (CHC) : Notable OTC brands like Champs, Flavettes, and Uphamol As of 2025, it exports to multiple countries and operates from 3 GMP-certified manufacturing facilities.
View narrative
RM 1.68
FV
20.8% undervalued
intrinsic discount
8.58%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
New
narrative
Value any company in seconds
Popular companies